[1]
“A Sensitive Bioanalytical Method Development And Validation Of Pazopanib In Human Plasma By LC-ESI-MS/MS”, Journal of Pharmaceutical Negative Results, pp. 855–861, Nov. 2022, Accessed: Jun. 10, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/3388